A state court Sept. 11 allowed a terminated IRB chairperson’s $30 million defamation lawsuit against a New York City hospital to go forward, ruling that statements at issue given during an FDA investigation weren’t privileged (Stega v. N.Y. Downtown Hosp., N.Y. Sup. Ct., 152716/13).
Jeanette Stega had argued that New York Downtown Hospital employees alleged to the hospital and to the Food and Drug Administration that she had stolen money paid by a clinical trial sponsor and that all clinical trial reviews of the “Internal Review Board” she led were “tainted.”
The Supreme Court of New York, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.